Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

由 Revicki Dennis A, van den Eertwegh Alfons JM, Lorigan Paul, Lebbe Celeste, Linette Gerald, Ottensmeier Christian H, Safikhani Shima, Messina Marianne, Hoos Axel, Wagner Samuel, Kotapati Srividya
出版 2012-06-01

Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

由 Revicki, Dennis A, van den Eertwegh, Alfons JM, Lorigan, Paul, Lebbe, Celeste, Linette, Gerald, Ottensmeier, Christian H, Safikhani, Shima, Messina, Marianne, Hoos, Axel, Wagner, Samuel, Kotapati, Srividya
出版 2012

Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition

由 Oosterhoff, Dinja, Lougheed, Sinéad, van de Ven, Rieneke, Lindenberg, Jelle, van Cruijsen, Hester, Hiddingh, Lotte, Kroon, Jan, van den Eertwegh, Alfons J.M., Hangalapura, Basav, Scheper, Rik J., de Gruijl, Tanja D.
出版 2012

Induction of dendritic cell maturation in the skin microenvironment by soluble factors derived from colon carcinoma

由 Lindenberg, Jelle J, van de Ven, Rieneke, Oosterhoff, Dinja, Sombroek, Claudia C, Lougheed, Sinéad M, Stam, Anita GM, Koenen, Hans JPM, van den Eertwegh, Alfons JM, Scheper, Rik J, de Gruijl, Tanja D
發表在 Hum Vaccin Immunother (2014)

Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab

由 Santegoets, Saskia JAM, Stam, Anita GM, Lougheed, Sinéad M, Gall, Helen, Jooss, Karin, Sacks, Natalie, Hege, Kristen, Lowy, Israel, Scheper, Rik J, Gerritsen, Winald R, van den Eertwegh, Alfons JM, de Gruijl, Tanja D
發表在 J Immunother Cancer (2014)

Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characterist...

由 van der Hiel, Bernies, Haanen, John B.A.G., Stokkel, Marcel P.M., Peeper, Daniel S., Jimenez, Connie R., Beijnen, Jos H., van de Wiel, Bart A., Boellaard, Ronald, van den Eertwegh, Alfons J.M.
發表在 BMC Cancer (2017)

Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an Adenovirus based melanoma vaccine

由 Hangalapura, Basav N, Oosterhoff, Dinja, Gupta, Tarun, de Groot, Jan, Wijnands, Pepijn GJTB, van Beusechem, Victor W., den Haan, Joke, Tüting, Thomas, van den Eertwegh, Alfons JM, Curiel, David T, Scheper, Rik J, de Gruijl, Tanja D
出版 2011

IL-21 promotes the expansion of CD27(+)CD28(+) tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells

由 Santegoets, Saskia JAM, Turksma, Annelies W, Suhoski, Megan M, Stam, Anita GM, Albelda, Steve M, Hooijberg, Erik, Scheper, Rik J, van den Eertwegh, Alfons JM, Gerritsen, Winald R, Powell, Daniel J, June, Carl H, de Gruijl, Tanja D
出版 2013

Functional characterization of a STAT3-dependent dendritic cell-derived CD14(+) cell population arising upon IL-10-driven maturation

由 Lindenberg, Jelle J., van de Ven, Rieneke, Lougheed, Sinéad M., Zomer, Anoek, Santegoets, Saskia J.A.M., Griffioen, Arjan W., Hooijberg, Erik, van den Eertwegh, Alfons J.M., Thijssen, Victor L., Scheper, Rik J., Oosterhoff, Dinja, de Gruijl, Tanja D.
出版 2013

Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Castration-Resistant Prostate Cancer Patients Treated with Abiraterone

由 Attard, Gerhardt, de Bono, Johann S., Logothetis, Christopher J., Fizazi, Karim, Mukherjee, Som D., Joshua, Anthony M., Schrijvers, Dirk, van den Eertwegh, Alfons J.M., Li, Weimin, Molina, Arturo, Griffin, Thomas W., Kheoh, Thian, Ricci, Deborah S., Zelinsky, Kathy, Rathkopf, Dana E., Scher, Howard I., Ryan, Charles J.
發表在 Clin Cancer Res (2015)

T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A(+)CD141(+) cDC1 and CD14(+) antigen-presenting cell recruitment

由 Koster, Bas D, López González, Marta, van den Hout, Mari FCM, Turksma, Annelies W, Sluijter, Berbel JR, Molenkamp, Barbara G, van Leeuwen, Paul AM, Vosslamber, Saskia, Scheper, Rik J, van den Eertwegh, Alfons JM, van den Tol, M Petrousjka, Jordanova, Ekaterina J, de Gruijl, Tanja D
發表在 J Immunother Cancer (2021)

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

由 De Remigis, Alessandra, de Gruijl, Tanja D, Uram, Jennifer N, Tzou, Schey-Cherng, Iwama, Shintaro, Talor, Monica V, Armstrong, Todd D, Santegoets, Saskia J A M, Slovin, Susan F, Zheng, Lei, Laheru, Daniel A, Jaffee, Elizabeth M, Gerritsen, Winald R, van den Eertwegh, Alfons JM, Le, Dung T, Caturegli, Patrizio
出版 2014

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

由 Hodi, F. Stephen, O’Day, Steven J., McDermott, David F., Weber, Robert W., Sosman, Jeffrey A., Haanen, John B., Gonzalez, Rene, Robert, Caroline, Schadendorf, Dirk, Hassel, Jessica C., Akerley, Wallace, van den Eertwegh, Alfons J.M., Lutzky, Jose, Lorigan, Paul, Vaubel, Julia M., Linette, Gerald P., Hogg, David, Ottensmeier, Christian H., Lebbé, Celeste, Peschel, Christian, Quirt, Ian, Clark, Joseph I., Wolchok, Jedd D., Weber, Jeffrey S., Tian, Jason, Yellin, Michael J., Nichol, Geoffrey M., Hoos, Axel, Urba, Walter J.
出版 2010

Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?

由 Schouwenburg, Maartje G., Suijkerbuijk, Karijn P.M., Koornstra, Rutger H.T., Jochems, Anouk, van Zeijl, Michiel C.T., van den Eertwegh, Alfons J.M., Haanen, John B.A.G., Aarts, Maureen J.B., van Akkooi, Alexander C.J., van den Berkmortel, Franchette W.P.J., de Groot, Jan Willem B., Hospers, Geke A.P., Kapiteijn, Ellen, Kruit, Wim H., Piersma, Djura, van Rijn, Rozemarijn S., ten Tije, Albert J., Vreugdenhil, Gerard, van der Hoeven, Jacobus J.M., Wouters, Michel W.J.M.
發表在 Cancers (Basel) (2019)